Bragar Eagel &amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options  If you purchased or acquired stock

ELEVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Elevance Health, Inc. on Behalf of Elevance Stockholders and Encourages Investors to Contact the Firm

Elevance Health Under Investigation After CMS Sanction Threat

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Bragar Eagel &amp;amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options  If you purchased or acquired stock</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Elevance Health is facing a legal investigation due to potential violations related to Medicare data submission. Following a recent announcement of sanctions by CMS, which could suspend Medicare enrollment, shares have already dropped significantly, indicating ongoing risk for investors.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Elevance Health faces legal investigation over potential securities law violations.</li><li>CMS plans to suspend Medicare enrollment due to data submission issues.</li><li>Elevance shares dropped 8.1% following CMS announcement.</li><li>Shareholders are encouraged to explore legal options for losses.</li><li>Sanctions could affect Elevance&#039;s financial performance and stock price.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Elevance Health, Inc. (ELV)</strong>: Potential sanctions and ongoing legal issues could affect revenue streams.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>The article falls under &#039;Legal&#039; due to the investigation into alleged securities law violations against Elevance, which is critical for understanding regulatory challenges and risk factors impacting its operations and stock performance.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>CMS sanctions threaten Elevance&#039;s enrollment in Medicare Advantage plans.</li><li>Legal investigations may increase operational risks and negatively impact investor sentiment.</li><li>Further declines in share price could prompt more investors to seek legal remedies.</li><li>Potential fines or operational disruptions from the CMS could impair future earnings.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>CMS announced intent to impose sanctions effective March 31, 2026.</li><li>Elevance shares fell by approximately 8.1% on March 2, 2026.</li><li>Investigation led by Bragar Eagel &amp; Squire, P.C.</li><li>Alleged violations relate to risk adjustment data for services prior to April 3, 2023.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Considering potential sanctions and ongoing legal investigations, ELV may face downward pressure in the short term.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify"><strong>Bragar Eagel &amp; Squire, P.C. </strong><strong>Litigation Partner </strong><a href="https://www.globenewswire.com/Tracker?data=7GjA9pkKLk6hYWNbtj2dd-seIhRT_BD6MV9c72wbM7u6uVp24cUKV1Si04A-6AYN36JSjrcd60VpZwdiAPbSDnqM_-uyoo2_clXFNJUTFvauyytrZLaE0VY97Or6QvKB" rel="nofollow" target="_blank"><strong>Brandon Walker</strong></a><strong> Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options</strong></p>  <p align="justify"><strong>If you purchased or acquired stock in </strong><strong>Elevance</strong><strong> and would like to discuss your legal rights, call Bragar Eagel &amp; Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.</strong></p>  <p align="justify">Click <a href="https://www.globenewswire.com/Tracker?data=orTRj-y5syFxAeq6TJMAq-rI-JvPpfBFL4YcAfbcnw40YD9lljb3xswm5ZLr0mPQ-Owhi3h_Gf_lOIsP95VD7A==" rel="nofollow" target="_blank">here</a> to participate in the action.</p>  <p align="justify">NEW YORK, April  20, 2026  (GLOBE NEWSWIRE) -- </p>  <p align="justify"><strong>What's Happening:</strong></p>  <ul type="circle"><li style="margin-bottom:12pt; text-align:justify;"><a href="https://www.bespc.com" rel="nofollow" target="_blank">Bragar Eagel &amp; Squire, P.C</a>., a nationally recognized stockholder rights law firm, is investigating potential claims against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ELV">ELV</a>) on behalf of Elevance stockholders. Our investigation concerns whether Elevance has violated the federal securities laws and/or engaged in other unlawful business practices.<br></br><br></br></li></ul>  <p align="justify"><strong>Investigation Details:</strong></p>  <ul type="circle"><li style="margin-bottom:12pt; text-align:justify;">On March 2, 2026, Elevance disclosed in a filing with the U.S. Securities and Exchange Commission that it "was notified by the Centers for Medicare &amp; Medicaid Services (‘CMS') of its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Company's Medicare Advantage-Prescription Drug (‘MA-PD') plans and suspending certain communication activities to Medicare beneficiaries." Elevance said that "CMS has indicated that the proposed sanctions relate to alleged noncompliance by the Company with certain Medicare Advantage risk adjustment data submission requirements for dates of service prior to April 3, 2023" and that "[t]he sanctions are scheduled to take effect on March 31, 2026 unless CMS determines that the issues identified have been satisfactorily addressed." On this news, the price of Elevance shares declined by $25.93 per share, or approximately 8.1%, from $320.00 per share on February 27, 2026 to close at $294.07 on March 2, 2026.<br></br><br></br></li></ul>  <p align="justify"><strong>Next Steps:</strong></p>  <ul type="circle"><li style="text-align:justify;">If you purchased or otherwise acquired Elevance shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact <a href="https://www.bespc.com/professionals/brandon-walker" rel="nofollow" target="_blank">Brandon Walker</a> or <a href="https://www.bespc.com/professionals/melissa-fortunato" rel="nofollow" target="_blank">Melissa Fortunato</a> by email at <a href="mailto:investigations@bespc.com" rel="nofollow" target="_blank">investigations@bespc.com</a>, by telephone at (212) 355-4648, or by <a href="https://bespc.com/cases/ELV" rel="nofollow" target="_blank">filling out this contact form</a>.  There is no cost or obligation to you.<br></br><br></br></li></ul>  <p align="justify"><strong>About Bragar Eagel &amp; Squire, P.C.:</strong></p>  <p align="justify">Bragar Eagel &amp; Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit <a href="https://www.globenewswire.com/Tracker?data=wqXvNmiHdSr5OjQ0NGwMvITdG8jnU-A2cQPoR4dbc9WFO6J9ntDVwjPfap5nXyMnIdZqMn9xWMMQyjaT8kLm9g==" rel="nofollow" target="_blank">www.bespc.com</a>.  Attorney advertising.  Prior results do not guarantee similar outcomes.</p>  <p align="justify">Follow us for updates on <a href="https://www.globenewswire.com/Tracker?data=JxAoi9VlnZkOTyWZ7PH4AvdJJH0uQNTshAMeuinJQ41TUk8LbCG3cKlpgl0wbqxdRArsmvyT5zvUEYRNTJtZ9hWTQjz9umUi0djPOSLMnyJnaPJ-VREA-QWT9BgDDkNz" rel="nofollow" target="_blank">LinkedIn</a> and <a href="https://www.globenewswire.com/Tracker?data=XYIAn-NLopIOc6O7RlIiFH8XayaL8trWq1vDetyjbUUbnPSyBw-FcsFlmwAK6W-ej0FJpqZlvgKJEE8B_-pH2I66WEw0GeDI-Yh5GtZGISdUltCehKKbrUyzc4JOMC2d" rel="nofollow" target="_blank">Facebook</a>, and keep up with other news by following Brandon Walker, Esq. on <a href="https://www.globenewswire.com/Tracker?data=JxAoi9VlnZkOTyWZ7PH4AmvIddqqsjiIElgUvfH_PtY_6Nb73a3Xbc3ZTMJ0KoY0v8zzoA0viLsOXMRcVdNC_mPq6_IxxFUg9G1qmdfs9NKGMS54WzCRQegb2weq6RbN" rel="nofollow" target="_blank">LinkedIn</a>.</p>  <p align="justify"><strong>Contact Information:</strong></p>  <p align="justify">Bragar Eagel &amp; Squire, P.C.<br></br>Brandon Walker, Esq.<br></br>Melissa Fortunato, Esq.<br></br>(212) 355-4648<br></br><a href="https://www.globenewswire.com/Tracker?data=BY4fVUTfM4bOKXR1uo4-dqHA-lXsQ2pTZdwXoFRhWfwv3EpKZkxxi_dFzM-Zriec6wtDsLbnGPNT9onT-zt5Ldn2UsU5XP_WiTDAjsxECgJ0l0HebclUa6FTIeQy0n_s" rel="nofollow" target="_blank"><u>investigations@bespc.com</u></a><br></br><a href="https://www.globenewswire.com/Tracker?data=wqXvNmiHdSr5OjQ0NGwMvD_APuzzXJcC-s0hHAFco5nhWwgGxmFm417PdJNfUe4GWAfGOW-JQX3JkNRLJUIIpw==" rel="nofollow" target="_blank"><u>www.bespc.com</u></a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY5MzQ1OCM3NTQ1ODM4IzIxMDAzOTg="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/ODM0ODUwZjgtZmI1Mi00Yjc4LTllYmQtOWY5OTM1MDhlNGFiLTExMTE5NjktMjAyNi0wNC0yMC1lbg==/tiny/Bragar-Eagel-Squire.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/29481954-f2ff-4756-b5a9-d982a6497bd0"><img src="https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg" border="0" width="150" height="75" alt="Primary Logo"></img></a></p>

Elevance Health is facing a legal investigation due to potential violations related to Medicare data submission. Following a recent announcement of sanctions by CMS, which could suspend Medicare enrollment, shares have already dropped significantly, indicating ongoing risk for investors.

elevance-investigation-alert-bragar-eagel-squire-p-c-is-investigating-elevance-health-inc-on-behalf-of-elevance-stockholders-and-encourages-investors-to-contact-the-firm

ELEVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Elevance Health, Inc. on Behalf of Elevance Stockholders and Encourages Investors to Contact the Firm

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News